FDA Okays First Sublingual Med for Agitation in Serious Mental Illness

Published by Joseph Thornton MD

Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts